Muthukumar R: What if One Blood Test Could Tell Doctors Much More Than it Does Today?
Muthukumar R, Founder & CEO of Azaygen India, shared a post on LinkedIn.
“What if one blood test could tell doctors much more than it does today?
That’s the kind of conversation we recently had at the Hematology Department of Christian Medical College (CMC) Vellore Ranipet Campus, while introducing the Randox Evidence MultiStat.
Under the guidance of Dr. Vikram Mathews , the discussion centered on how modern diagnostics are shifting toward seeing the bigger clinical picture especially in understanding Inflammation and immune response.
Instead of running multiple separate tests, the MultiStat can Analyze 9 key biomarkers in a single run. This allows clinicians to understand what’s happening inside the body faster.
And more clearly, whether the concern is infection, clotting complications ,or hematologic disorders.
Markers such as IL-6, TNF-α, Interferon-Gamma, and IL-2 play a critical role in immune regulation and inflammatory pathways.
The ability to obtain insights on these markers in around 60 minutes is especially valuable when managing critically ill patients.
What stood out most was how easily the system fits into real lab workflows compact, efficient, and built for high-volume environments where time truly matters.
More than a technology introduction,it was a meaningful exchange of ideas on where diagnostics is heading. And how precision medicine is becoming increasingly practical.Progress like this happens through collaboration.
And a willingness to rethink how we interpret the body’s signals.”

Stay updated with Hemostasis Today.
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care